What does the research say about Meridia?
Sibutramine, the active ingredient in MERIDIA, has been extensively studied throughout the world. It has been studied in more than 100 clinical trials involving more than 12,000 patients. It was first approved in 1997. In research studies, “sibutramine in combination with diet and exercise was effective in producing and maintaining significant weight loss in the majority of obese patients compared to diet and exercise alone.” ((http://www.rxabbott.com/pdf/meridia.pdf)) The safety and effectiveness of Meridia have not yet been established beyond two years’ time.
